Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04978207 · ClinicalTrials.gov registry record · NA
A Faithful Response to COVID-19 Project
A NA study, sponsored by University of Missouri, Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 1,013
- Enrollment target
NCT04978207: Completed NA study, sponsored by University of Missouri, Kansas City.
NCT04978207 is a NA study that has completed, run by University of Missouri, Kansas City. The registered enrollment target is 1,013 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04978207, a NA study, has completed, sponsored by University of Missouri, Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,013 participants
- Enrollment target
Study Summary
This 2-arm clustered, randomized community trial will test a multilevel, COVID-19 testing and linkage to care (eg, health insurance, medical appointments, community resources, contact tracing) intervention against a nontailored, attention-control condition on uptake of COVID-19 testing with adult African American church-affiliated members at 6 months. Contact tracing approval (beliefs and participation contact tracing) and COVID19 prevention behaviors will also be examined. Findings from this study could provide a theory-based, multilevel model for delivering scalable, wide-reaching COVID-19 testing and linkage to care services, including contact tracing, by supporting African American faith leaders with culturally-appropriate, easy-to-use tools and health agency partnerships.
Primary Outcome
COVID19 Testing will be assessed via self-report (ever, last 6 months, month/day/year) and objectively assessed with data reports provided by the Kansas City MO Health Department
Interventions
- BEHAVIORAL A Faithful Response to COVID-19
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,013 participants |
| Start Date | 2021-06-06 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04978207 record still lists
NCT04978207 is an interventional study that assigns participants to a tested intervention. Its 1,013 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 1 intervention - of which A Faithful Response to COVID-19 is the first listed.
NCT04978207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04978207 about?
NCT04978207 is a clinical study titled "A Faithful Response to COVID-19 Project". This 2-arm clustered, randomized community trial will test a multilevel, COVID-19 testing and linkage to care (eg, health insurance, medical appointments, community resources, contact tracing) intervention against a nontailored, attention-control condition on uptake of COVID-19 testing with adult Af...
What is the current status of trial NCT04978207?
This trial is currently completed. It is a NA study. The enrollment target is 1,013 participants. The study started on 2021-06-06. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04978207?
The interventions under investigation include: A Faithful Response to COVID-19 (BEHAVIORAL).
Who is sponsoring clinical trial NCT04978207?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04978207's enrollment target sits among peer trials
1,013 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI